A detailed history of Western Wealth Management, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Western Wealth Management, LLC holds 20,000 shares of AUPH stock, worth $179,000. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,000
Holding current value
$179,000
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$5.32 - $7.33 $106,400 - $146,600
20,000 New
20,000 $146,000
Q2 2022

Jul 18, 2022

SELL
$8.95 - $12.8 $5,370 - $7,680
-600 Reduced 2.2%
26,650 $269,000
Q1 2022

May 10, 2022

BUY
$10.05 - $22.48 $273,862 - $612,580
27,250 New
27,250 $338,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.27B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Western Wealth Management, LLC Portfolio

Follow Western Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Western Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Western Wealth Management, LLC with notifications on news.